{"id":"W4413605538","doi":"10.1016/j.bneo.2025.100165","title":"Final safety and efficacy results from a phase 1/2 study of tagraxofusp, a CD123-targeted therapy, for myelofibrosis","year":2025,"lang":"en","type":"article","venue":"Blood Neoplasia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta Hospital; Princess Margaret Cancer Centre","funders":"Menarini Group","keywords":"Myelofibrosis; Medicine; Phase (matter); Targeted therapy; Oncology; Internal medicine; Chemistry; Bone marrow; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001986569,0.0009538003,0.001217069,0.000250307,0.0003762372,0.0005499793,0.0004728769,0.0008488537,0.001797192],"category_scores_gemma":[0.001270823,0.0003099763,0.000880196,0.000195113,0.0005370163,0.0004555725,0.0001919885,0.001902713,0.0004005269],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004448438,"about_ca_system_score_gemma":0.0008317211,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005329964,"about_ca_topic_score_gemma":0.0009842878,"domain_scores_codex":[0.9994836,0.0002950093,0.00003132974,0.00006485589,0.00005153508,0.00007357663],"domain_scores_gemma":[0.9991947,0.0002215117,0.0001287925,0.00008781037,0.00008578647,0.0002814722],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4763322,0.06541855,0.01798634,0.001065054,0.001653044,0.001551255,0.0006613084,0.00702929,0.2353515,0.0004648918,0.01142649,0.1810601],"study_design_scores_gemma":[0.220649,0.7137631,0.03127469,0.00005369121,0.0009658829,0.001204836,0.00006923611,0.002206536,0.02322168,0.00038744,0.006156112,0.00004776173],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991316,0.001616617,0.001349696,0.0003978506,0.00005305711,0.001717108,0.001882485,0.00009465093,0.00157259],"genre_scores_gemma":[0.9893396,0.00101435,0.001814703,0.0006289863,0.0001033208,0.001334728,0.004442529,0.0000358935,0.001285867],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001986569,"threshold_uncertainty_score":0.01050609,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02681857350839703,"score_gpt":0.3159203222997793,"score_spread":0.2891017487913823,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}